UNCLAIMED
Rho
Overview
Rho is a company operating in the Business Services industry, specifically within the realms of research and development, and clinical laboratory services, primarily for the biotech and pharmaceuticals sectors. Founded in 1984 and based in the United States, Rho employs between 201 and 500 individuals and reported revenue of approximately $105.7 million. The company has established a collaborative partnership with Anthera Pharmaceuticals, focusing on the development of innovative therapies for cystic fibrosis. Rho's involvement includes managing complex clinical studies, such as the pivotal SOLUTION study for Anthera's investigational product, liprotamase, which aims to provide a non-pig derived pancreatic enzyme replacement therapy. Rho's expertise encompasses project management, regulatory support, and maintaining high-quality deliverables, which have allowed them to effectively support Anthera through various stages of product development, including the preparation of Biologics License Applications. The company's commitment to operational efficiencies and strong site relationships is evident in their approach to clinical trial management.